Rochester, MN, United States of America

David N Fass


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by David N Fass

Introduction

David N Fass is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of immunology, particularly in the development of highly sensitive assays for blood factor VIII. With a total of 2 patents, his work has important implications for the treatment of blood coagulation disorders.

Latest Patents

Fass's latest patents focus on highly sensitive immunoassays and antibodies for the detection of blood factor VIII. These patents disclose antibodies that selectively bind to blood coagulation factor FVIII. The preferred assays can detect FVIII at about 3500-fold below normal physiological levels. This innovation has a wide array of applications, including accurate monitoring of FVIII concentration in pharmaceutical products for treating blood coagulation disorders. Additionally, it aids in determining FVIII levels in the plasma of human patients, including those suffering from conditions such as hemophilia.

Career Highlights

David N Fass is affiliated with the University of Vermont and State Agricultural College. His work has been instrumental in advancing the understanding and treatment of blood coagulation disorders. His research has garnered attention for its potential to improve patient outcomes significantly.

Collaborations

Fass has collaborated with notable colleagues, including Behnaz Parhami-Seren and Kenneth G Mann. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

David N Fass is a distinguished inventor whose work in immunology has led to significant advancements in the detection and treatment of blood coagulation disorders. His contributions continue to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…